Latest News for Gathid Stock (OTC:RCWDF)

Gathid Ltd Formerly RightCrowd Ltd is a developer of physical security, safety, and compliance software. Its operating segment are Workforce Management which involves development and delivery of RightCrowd's core Workforce and Visitor Management Solutions; Presence Control which involves development and delivery of RightCrowd's Presence Control solutions and Access Analytics which involves development and delivery of analytics software for identifying user access compliance issues. Geographically, it derives a majority of revenue from North America and also has a presence in Europe, Middle East and Africa; Latin America and Oceania and Australia.

Gathid Ltd

Needham analyst Alex Henderson reiterates Juniper Networks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNPR#NYSE">JNPR</a>) with a Hold.

News

Reiteration

Analyst Ratings

JNPR

Needham Reiterates Hold on Juniper Networks

With BEQVEZ now approved for use, Pfizer is launching an innovative warranty program based on durability of patient response to treatment. The goal of the warranty is to provide greater certainty to payers, maximize access for eligible patients who receive BEQVEZ, and offer financial protection by insuring against the risk of efficacy failure.
"For people living with hemophilia, disease management can interfere with many aspects of their lives. A one-time infusion of BEQVEZ may allow eligible patients more time for the things they love," said Kim Phelan, Chief Operating Officer, The Coalition for Hemophilia B. "We are excited to have BEQVEZ as a promising treatment option for eligible people living with hemophilia B. We look forward to learning more and celebrating with the community and with Pfizer at our annual conference that is currently taking place."
BEQVEZ is currently under review with the European Medicines Agency (EMA), and the treatment recently received regulatory approval in Canada. In addition to BEQVEZ, Pfizer currently has two other Phase 3 programs investigating gene therapy in populations where there is a high unmet need: hemophilia A (giroctocogene fitelparvovec) and Duchenne muscular dystrophy (fordadistrogene movaparvovec). Additionally, a Phase 3 trial is investigating marstacimab, a novel, investigational anti-tissue factor pathway inhibitor for the treatment of people with hemophilia A and B with and without inhibitors. A Biologics License Application and European Marketing Authorization Application for marstacimab are currently under review with the FDA and EMA, respectively.

Pfizer Says U.S. FDA Approved Company's BEQVEZ (fidanacogene elaparvovec-dzkt), A One-Time Gene Therapy For Adults With Hemophilia B; Company Now Plans Launching An Innovative Warranty Program Based On Durability Of Patient Response To Treatment

Tech earnings could come to the market&#8217;s rescue as traders remain jittery about the outcome of key inflation data due on Friday. AI giants&nbsp;Alphabet, Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) and&nbsp;Microsoft Corp.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) set a positive tone for tech companies with strong performances&nbsp;<a target="_blank" href="https://www.benzinga.com/news/earnings/24/04/38445001/alphabet-q1-earnings-revenue-beat-eps-beat-70b-buyback-first-ever-dividend-ai-leadership-and-more" rel="noreferrer noopener">in the first quarter</a>.
However, the focus will likely shift to the annual inflation rate, as measured by the Personal Consumption Expenditures Price Index (PCE), the Federal Reserve&#8217;s preferred gauge. This data, released as part of the personal income and spending report at 8:30 am ET, could provide a double boost to the market. A reading in line with or below expectations could help break the recent lackluster performance.
The PCE data is particularly important because the Federal Open Market Committee (FOMC), the Fed&#8217;s policy-setting arm, meets next Wednesday. The futures market currently prices in a 97% chance of the Fed holding rates steady.
 Futures Performance On Friday ( as of 6:15 a.m. EDT)
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Performance (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>+0.99%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>+0.70%</td>
</tr>
<tr>
<td>Dow</td>
<td>+0.15%</td>
</tr>
<tr>
<td>R2K</td>
<td>-0.26%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption"> In <a href="https://www.benzinga.com/premarket/" target="_blank" rel="noreferrer noopener">premarket</a>&nbsp;trading on Friday, the&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) climbed 0.70% to $507.02,&nbsp;and the&nbsp;Invesco QQQ ETF&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) rallied 0.93% to $428.40, according to&nbsp;<a href="https://benzinga.grsm.io/lxquj26b2sag" target="_blank" rel="noreferrer noopener">Benzinga Pro data</a>.</figcaption></figure>
Cues From Past Session:
A mixed first-quarter GDP data that showed weaker growth and a rise in an inflation gauge as well as negative reactions to tech earnings sent traders on the defensive on Thursday. The major averages opened notably lower but they trimmed their losses in the session, although they ended notably lower.
Communication services stocks plunged, led lower by Meta Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>)
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>-0.64%</td>
<td>15,611.76</td>
</tr>
<tr>
<td>S&amp;P 500 Index</td>
<td>-0.46%</td>
<td>5,048.42</td>
</tr>
<tr>
<td>Dow Industrials</td>
<td>-0.98%</td>
<td>38,085.80</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.72%</td>
<td>1,981.12</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
While conceding that the strength of the bull market has waned, an analyst said he does not see the end of it.
&#8220;The end of prolonged below-average bearish sentiment and above-average bullish sentiment implies investors may be losing some confidence in the strength of this bull market,&#8221; said LPL Financial Chief Technical Strategist Adam Turnquist. Technical evidence also supported this observation, he said, adding that dip-buyers stopped showing up near the S&amp;P 500's 20-day moving average earlier this month, providing a timely signal for a deeper pullback. 
The analyst, however, said the recent shift in sentiment may not mark the end of the bull market. Technically, he sees the 4,800 area on the S&amp;P 500 as a worst-case scenario in the eventuality of a pullback. 
&#8220;Confidence for a relatively limited drawdown is supported by breadth metrics holding up well, cyclical sector leadership, limited signs of panic in credit or volatility gauges, economic resiliency, and the longer-term momentum implications of this rally,&#8221; he said.
Carson Group&#8217;s Ryan Detrick also exuded optimism, albeit for a different reason. He noted that the &#8220;sell in May and go away&#8221; adage does not apply to the presidential election years. The May-October period, which typically is a weaker period for the market, tends to do well during election years, he said.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Sell in May? Did you know that these &#39;worst six months&#39; tend to do quite well in an Election year? In fact, up nearly 78% of the time. <a href="https://t.co/F2FNrWk3Fw">pic.twitter.com/F2FNrWk3Fw</a>
&mdash; Ryan Detrick, CMT (@RyanDetrick) <a href="https://twitter.com/RyanDetrick/status/1783600133482873145?ref_src=twsrc%5Etfw">April 25, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<figcaption class="wp-element-caption">Upcoming Economic Data:</figcaption></figure>
The Commerce Department is scheduled to release its personal income and spending report for March at 8:30 a.m. EDT. On a month-over-month basis, the metrics may have increased 0.5% and 0.7%, respectively, in March compared to the 0.3% and 0.8% growth in February.
The price consumption expenditure index is expected to rise 0.3% month-over-month and 2.6% year-over-year. This compares to the February rates of 0.3% and 2.5%, respectively. The monthly rate of the core price consumption expenditure index may have remained unchanged at 0.3% and the annual rate may have slowed from 2.8% to 2.7%.
The University of Michigan&#8217;s final consumer sentiment index for April, due at 10 a.m. EDT, is expected to show the reading remained almost unchanged from the flash reading of 77.9, but down from 79.4 in March. Trades may also focus on the inflation expectations readings of the report.
See also: <a href="https://www.benzinga.com/money/best-futures-trading-software">Best Futures Trading Software</a>
Stocks In Focus: 
<ul>
<li>Alphabet climbed nearly 12% <a href="https://www.benzinga.com/premarket">in premarket trading </a>following its quarterly results announcement and dividend initiation and Microsoft rose a more modest 4%. Most AI-levered stocks moved in sympathy.</li>
<li>Other stocks moving on earnings are Boyd Gaming Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BYD#NYSE">BYD</a>) (down over 10%), Intel Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) (down nearly 7.5%), Roku, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>) (down over 3%), ResMed Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RMD#NYSE">RMD</a>) (up over 11%), Skechers U.S.A., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKX#NYSE">SKX</a>) (up about 11.5%) and Teladoc Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDOC#NYSE">TDOC</a>) (down over 5%).</li>
<li> AbbVie Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>), Aon plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>), Autoliv, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALV#NYSE">ALV</a>), AutoNation, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AN#NYSE">AN</a>), Barnes Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/B#NYSE">B</a>), Charter Communications, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHTR#NASDAQ">CHTR</a>), Colgate-Palmolive Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>), Chevron Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>), Exxon Mobil Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) and Newell Brands Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWL#NASDAQ">NWL</a>) are among the <a href="https://www.benzinga.com/calendars/earnings">companies due to report their quarterly results ahead of the market open.</a></li>
</ul>
Commodities, Bonds, and Global Equity Markets:
Crude oil futures rose for a second straight session, reversing their recent losses, and approached the $84-a-barrel mark, and gold futures also advanced to around $2,360 an ounce.
The 10-year note yield pulled back from Thursday&#8217;s level and yet held around the 4.68% mark.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) gained modestly to around the $64.3K level.
Asian stocks ended Friday&#8217;s session on a mixed note, with most rebounding from the previous session&#8217;s sell-off. The Chinese and Hong Kong markets extended their gains, while Australia and New Zealand moved lower in a catchup move after remaining closed on Thursday.&#8217;
The Bank of Japan on Friday kept its policy rate unchanged but it lowered its growth forecasts for the economy. 
Major European markets advanced in early trading, reversing from Thursday&#8217;s retreat, with the Euro STOXX 50 gaining about 0.68%.
Read Next: <a href="https://www.benzinga.com/economics/macro-economic-events/24/04/38438240/feds-inflation-report-looms-this-friday-what-makes-it-so-crucial-for-markets">Fed&#8217;s Inflation Report Looms This Friday: What Makes It So Crucial For Markets?</a>
Photo via Shutterstock

Earnings

Equities

Futures

Previews

Economics

Federal Reserve

Pre-Market Outlook

Markets

Movers

Trading Ideas

$BTC

ABBV

CHTR

GOOG

GOOGL

INTC

MSFT

ROKU

TDOC

Wall Street Futures Ride High On Microsoft, Alphabet Cheer, But Will Inflation Data Burst The Bubble? Why This Analyst Thinks Bull Run Isn't Over Yet

B of A Securities analyst Ronald Epstein downgrades Teledyne Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDY#NYSE">TDY</a>) from Buy to Neutral and lowers the price target from $490 to $400.

Downgrades

Price Target

B of A Securities Downgrades Teledyne Technologies to Neutral, Lowers Price Target to $400

Needham analyst Matt Dezort reiterates Check Point Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHKP#NASDAQ">CHKP</a>) with a Hold.

CHKP

Needham Reiterates Hold on Check Point Software

GrafTech International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EAF#NYSE">EAF</a>) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.12) by 16.67 percent. This is a 400 percent decrease over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $136.58 million which beat the analyst consensus estimate of $125.69 million by 8.67 percent. This is a 1.60 percent decrease over sales of $138.80 million the same period last year.

Earnings Beats

GrafTech International Q1 Adj $(0.10) Beats $(0.12) Estimate, Sales $136.58M Beat $125.69M Estimate

Citigroup analyst Ronald Josey maintains Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) with a Buy and raises the price target from $168 to $190.

Citigroup Maintains Buy on Alphabet, Raises Price Target to $190

Needham analyst Mayank Tandon maintains SS&amp;C Techs Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSNC#NASDAQ">SSNC</a>) with a Buy and raises the price target from $70 to $74.

SSNC

Needham Maintains Buy on SS&C Techs Hldgs, Raises Price Target to $74

OUTLOOK
In the&nbsp;second quarter, the company expects seasonal demand improvements across most businesses.&nbsp; Low costs for natural gas and NGLs should continue to benefit margins from LYB&#39;s North American and&nbsp;Middle East&nbsp;production relative to higher oil-based costs in most other regions.&nbsp; With the start of the summer driving season, oxyfuels and refining margins are expected to increase with higher gasoline crack spreads and lower butane costs.&nbsp; During the&nbsp;second quarter, LYB expects to operate its assets in line with market demand with average operating rates of&nbsp;85%&nbsp;for global olefins and polyolefins assets and&nbsp;80%&nbsp;for the Intermediates &amp; Derivatives assets.&nbsp; The company continues to monitor targeted stimulus efforts and remains watchful for demand improvements in&nbsp;China.

LyondellBasell For Q2 Expects Seasonal Demand Improvements Across Most Businesses

Barclays analyst Ross Sandler maintains Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) with a Overweight and raises the price target from $173 to $200.

Barclays Maintains Overweight on Alphabet, Raises Price Target to $200

Needham analyst Joseph Stringer reiterates Rhythm Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYTM#NASDAQ">RYTM</a>) with a Buy and maintains $50 price target.

RYTM

Needham Reiterates Buy on Rhythm Pharmaceuticals, Maintains $50 Price Target

For Nextracker, this latest expansion also marks 20 new or expanded U.S. manufacturing partner facilities since 2021 and enables the company to provide over 25 GW of U.S. solar tracker capacity each year.

Nextracker And Jennmar Holdings Subsidiary JM Steel Jointly Announced Completion Of Major Expansion Of Nextracker-dedicated Manufacturing Lines At JM Steel's Leetsdale Steel Facility Achieving 4 GW Of Capacity

The company announced that its Board of Directors has declared a quarterly dividend of&nbsp;$0.165&nbsp;per share of common stock, or&nbsp;$0.66&nbsp;per share on an annualized basis. The&nbsp;first quarter&nbsp;2024 dividend will be paid on May 14, 2024 to all stockholders of record on May 7, 2024.
In connection with the extension, the Board of Directors replenished the amount of shares authorized for repurchase under the Share Repurchase Program, resulting in available capacity of&nbsp;$50 million.

Buybacks

AROC

Archrock Reports Extension Of Share Repurchase Program For An Additional 24-Month Period

Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) defied expectations this week, experiencing a price increase of around 3.7% even as investors pulled a significant amount of money out of Bitcoin <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38427873/blackrocks-spot-bitcoin-etf-sees-zero-inflows-as-net-outflows-tally-130m-on-wednesday">exchange-traded funds (ETFs)</a>.
What Happened: According to <a href="https://sosovalue.xyz/assets/etf">data</a> from SoSoValue, the total net outflow from Bitcoin spot ETFs on Thursday was a hefty $218 million. 
This outflow marks the first time that Fidelity&#8216;s (BATS:<a class="ticker" href="https://www.benzinga.com/stock/FBTC#BATS">FBTC</a>) and Valkyrie&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRRR#NASDAQ">BRRR</a>) ETFs witnessed net withdrawals of $22.61 million and $20.16 million, respectively. 
Grayscale&#8216;s industry-leading (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GBTC#OTC">GBTC</a>) ETF shouldered the brunt of the outflows, experiencing a net loss of $139 million on Thursday.
Franklin Templeton&#8216;s EZBC (BATS:<a class="ticker" href="https://www.benzinga.com/stock/EZBC#BATS">EZBC</a>) was the lone bright spot, recording a modest daily net inflow of $1.87 million, while BlackRock&#8217;s iShares Bitcoin Trust (NASDAQ: <a href="https://www.benzinga.com/quote/IBIT">IBIT</a>) recorded its second straight day of no new inflows.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/"><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" /></a></figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38441774/consensys-sues-sec-over-ethereum-classification-calls-for-regulatory-clarity">Consensys Sues SEC Over Ethereum Classification, Calls For Regulatory Clarity</a>
Despite the overall negative sentiment in the ETF market, the price of Bitcoin continues to climb, suggesting a potential disconnect between investor sentiment in the ETF market and the underlying asset itself.
This disconnect is further supported by research from JPMorgan, which indicates a weakening correlation between Bitcoin ETF prices and investor inflows, according to a Coindesk <a href="https://www.coindesk.com/markets/2024/04/26/bitcoin-stable-above-64k-while-etf-outflows-hit-200m/?utm_medium=referral&amp;utm_source=rss&amp;utm_campaign=headlines">report</a>.
While the outflows are significant, it&#8217;s worth noting that they come on the heels of a strong week for Bitcoin, with its price climbing nearly 4%. 
Additionally, liquidation data suggests a relatively stable market, with only $13.48 million worth of Bitcoin longs being liquidated in the past 24 hours.
What&#8217;s Next: The recent outflows from <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38431467/morgan-stanley-considers-broader-bitcoin-etf-sales-through-broker-network">Bitcoin spot ETFs</a> raise questions about investor sentiment and the future of this investment vehicle. Will this trend continue, or is it a temporary blip? 
What are the long-term implications for the Bitcoin market?
The Benzinga <a href="https://www.benzinga.com/events/digital-assets/agenda/">Future of Digital Assets</a> event, scheduled for Nov. 19, will bring together industry leaders, analysts, and investors to <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38441774/consensys-sues-sec-over-ethereum-classification-calls-for-regulatory-clarity">discuss these critical issues.</a>
Read Next: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38439558/bitcoin-options-on-hold-sec-delays-decision-seeks-public-input">Bitcoin Options On Hold: SEC Delays Decision, Seeks Public Input</a>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

BRRR

Franklin Bitcoin ETF Franklin Bitcoin ETF

EZBC

Fidelity Wise Origin Bitcoin Fund Fidelity Wise Origin Bitcoin Fund

FBTC

GBTC

IBIT

Spot Bitcoin ETFs Clobbered By $218M Net Outflow On Thursday

Needham analyst Ryan MacDonald maintains Accolade (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACCD#NASDAQ">ACCD</a>) with a Buy and lowers the price target from $17 to $13.

ACCD

Needham Maintains Buy on Accolade, Lowers Price Target to $13

Barclays analyst Christine Cho upgrades Enphase Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>) from Equal-Weight to Overweight and announces $134 price target.

Upgrades

ENPH

Barclays Upgrades Enphase Energy to Overweight, Announces $134 Price Target

NatWest Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NWG#NYSE">NWG</a>) reported quarterly earnings of $0.26 per share. This is a 16.13 percent decrease over earnings of $0.31 per share from the same period last year. The company reported $4.407 billion in sales this quarter. This is a 6.39 percent decrease over sales of $4.708 billion the same period last year.

NatWest Group Q1 2024 GAAP EPS $0.26 Down From $0.31 YoY, Sales $4.407B Down From $4.708B YoY

OCGN

Ocugen Says It Will Present On Modifier Gene Therapy Platform At Association For Research In Vision And Ophthalmology 2024 Annual Meeting

Guidance

Barnes Raised FY24 Adjusted EPS To $1.62-$1.82 (From $1.55-$1.80) Vs. $1.70 Est.

As a result, it was determined that the Ault Global Real Estate Equities assets and liabilities previously presented as assets and liabilities held for sale within the Company's balance sheet will no longer meet the held for sale criteria. Assets of $91.0 million and liabilities of $70.4 million as of December 31, 2023 were reported as assets and liabilities held for sale. In future periods, assets and liabilities of AGREE will be reclassified to assets and liabilities held and used and amounts previously presented in discontinued operations will be reclassified into continuing operations for all periods presented.

AULT

Ault Alliance Says It Has Ended Marketing Process For Its Four Hotels Owned And Operated By Wholly Owned Subsidiary, Ault Global Real Estate Equities

Rightcrowd Limited (AU:GTH) has released an update. Gathid Ltd, previously known as RightCrowd Limited, reported a significant revenue increase of ...

Gathid Ltd Reports Strong Half-Year Growth

Rightcrowd Limited (AU:GTH) has released an update. Rightcrowd Limited reports a challenging period after selling their physical security business,...

Rightcrowd Navigates Challenges and Eyes Growth

Rightcrowd Limited (AU:GTH) has released an update. Gathid Ltd has released its quarterly cash flow statement, revealing payments of $0.146m to its...